Harri Salo joins Eevia Health Plc as Chief Manufacturing Officer to strengthen top management competence and capacity
Eevia Health Plc, (”Eevia” or ”The Company”), is welcoming Harri Salo as our new Chief Manufacturing Officer. Harri Salo has a 15-year strong career in operations and production management in international industrial business environments. He will start Monday, January 10th, and significantly strengthen Eevia Health’s management capacity and competence for developing production organization, operation, and business processes.
Harri Salo comes from a position at 9Solutions being responsible for health care delivery projects. Previously, he was head of operations at Specim, responsible for complex industrial camera production. He has experience as a project manager from Nokia and Flextronics, including expatriate positions in South-East Asia supervising ODM outsourced manufacturing. Harri’s educational background is a Master of Science in Industrial Engineering and Management from the University of Oulu (2002).
“We are delighted to welcome Harri Salo to our team. He is superbly structured, analytical, and competent and will help us develop our manufacturing operations to a world-class level and secure our ability to deliver on high volume deals. His broad understanding of business processes, combined with strong leadership competence for both people and processes, is a great addition to our top team.” Stein Ulve, CEO
Harri Salo will join Eevia Health on Monday, January 10th, 2022. As our new Chief Manufacturing Officer, he will overtake the manufacturing organization, which includes two production managers, five shift leaders, and 12 operators and technicians. He will take a key position in the Top Management Team. With his background in Six Sigma Lean operations and ISO quality management assurance systems, he can support our efforts to streamline our production and delivery systems.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc Kim Nurmi-Aro, CFO, Eevia Health Plc
Telephone: +358 400 22 5967 +358 504 44 0717
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild-harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.